Annual Retained Earnings
-$471.56 M
-$98.43 M-26.38%
31 December 2023
Summary:
Foghorn Therapeutics annual retained earnings is currently -$471.56 million, with the most recent change of -$98.43 million (-26.38%) on 31 December 2023. During the last 3 years, it has fallen by -$308.63 million (-189.42%). FHTX annual retained earnings is now -996.46% below its all-time high of -$43.01 million, reached on 31 December 2018.FHTX Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Retained Earnings
-$538.68 M
-$19.12 M-3.68%
30 September 2024
Summary:
Foghorn Therapeutics quarterly retained earnings is currently -$538.68 million, with the most recent change of -$19.12 million (-3.68%) on 30 September 2024. Over the past year, it has dropped by -$91.22 million (-20.39%). FHTX quarterly retained earnings is now -472.24% below its all-time high of -$94.14 million, reached on 31 December 2019.FHTX Quarterly Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
FHTX Retained Earnings Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -26.4% | -20.4% |
| 3 y3 years | -189.4% | -129.1% |
| 5 y5 years | -996.5% | - |
FHTX Retained Earnings High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -189.4% | at low | -129.1% | at low |
| 5 y | 5 years | -996.5% | at low | -472.2% | at low |
| alltime | all time | -996.5% | at low | -472.2% | at low |
Foghorn Therapeutics Retained Earnings History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | -$538.68 M(+3.7%) |
| June 2024 | - | -$519.56 M(+4.6%) |
| Mar 2024 | - | -$496.58 M(+5.3%) |
| Dec 2023 | -$471.56 M(+26.4%) | -$471.56 M(+5.4%) |
| Sept 2023 | - | -$447.46 M(+3.3%) |
| June 2023 | - | -$433.11 M(+7.3%) |
| Mar 2023 | - | -$403.63 M(+8.2%) |
| Dec 2022 | -$373.14 M | -$373.14 M(+8.4%) |
| Sept 2022 | - | -$344.25 M(+8.1%) |
| June 2022 | - | -$318.48 M(+9.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2022 | - | -$291.17 M(+10.2%) |
| Dec 2021 | -$264.26 M(+62.2%) | -$264.26 M(+12.4%) |
| Sept 2021 | - | -$235.11 M(+12.5%) |
| June 2021 | - | -$209.03 M(+12.4%) |
| Mar 2021 | - | -$185.92 M(+14.1%) |
| Dec 2020 | -$162.94 M(+73.1%) | -$162.94 M(+14.6%) |
| Sept 2020 | - | -$142.18 M(+14.8%) |
| June 2020 | - | -$123.81 M(+31.5%) |
| Dec 2019 | -$94.14 M(+118.9%) | -$94.14 M |
| Dec 2018 | -$43.01 M | - |
FAQ
- What is Foghorn Therapeutics annual retained earnings?
- What is the all time high annual retained earnings for Foghorn Therapeutics?
- What is Foghorn Therapeutics annual retained earnings year-on-year change?
- What is Foghorn Therapeutics quarterly retained earnings?
- What is the all time high quarterly retained earnings for Foghorn Therapeutics?
- What is Foghorn Therapeutics quarterly retained earnings year-on-year change?
What is Foghorn Therapeutics annual retained earnings?
The current annual retained earnings of FHTX is -$471.56 M
What is the all time high annual retained earnings for Foghorn Therapeutics?
Foghorn Therapeutics all-time high annual retained earnings is -$43.01 M
What is Foghorn Therapeutics annual retained earnings year-on-year change?
Over the past year, FHTX annual retained earnings has changed by -$98.43 M (-26.38%)
What is Foghorn Therapeutics quarterly retained earnings?
The current quarterly retained earnings of FHTX is -$538.68 M
What is the all time high quarterly retained earnings for Foghorn Therapeutics?
Foghorn Therapeutics all-time high quarterly retained earnings is -$94.14 M
What is Foghorn Therapeutics quarterly retained earnings year-on-year change?
Over the past year, FHTX quarterly retained earnings has changed by -$91.22 M (-20.39%)